Chamber Cardio
Founded 2022 Β· 109 employees on LinkedIn Β· 7 known investors
Chamber provides care coordination software for healthcare systems operating under value-based care models, with a specific focus on improving cardiovascular outcomes through better data alignment and team coordination.
Also known as Chamber Β· Chamber Cardio
Investors Β· 7
Also in the syndicate Β· 2
Funding
SEC filings, press & company announcements- Undisclosed amountseed fundingMar 2024Source β
Source: company announcements and press reports β follow each round's link for the claim.
Company profile
researched Aug 2026Chamber Cardio, which operates as "Chamber," builds technology and operational infrastructure that supports cardiologists and health plans in managing patients with cardiovascular disease under value-based care arrangements. The company's platform aggregates cardiology signals, workflows and patient context, integrates directly with practices' electronic health records, and applies workflow-native AI to prioritize high-risk patients, identify gaps in guideline-directed therapy and reduce manual chart review. Alongside the software, Chamber supplies dedicated care teams that act as an extension of practices, plus value-based contracting support, analytics, evidence-based guidance and local physician networking that connects cardiologists with primary care referral sources.
The company describes a dual-sided model that serves cardiologists, patients and payers simultaneously: practices receive additive support and are rewarded for outcomes, patients are intended to experience more timely and coordinated care with fewer gaps, and payers gain clearer visibility into cardiovascular performance and total cost of care while benefiting from reduced hospital utilization. Chamber states it does not acquire practices, instead bringing them into a network through partnerships and wrapping care teams and technology around them. Reported outcome categories on its site include decreases in total inpatient admissions, CHF-related admissions and emergency room admissions, and reductions in total cost of care for congestive heart failure patients.
Founding story
Chamber was co-founded by George Aloth, a former Blue Cross Blue Shield health plan president and CEO and value-based kidney care executive who was group president at Somatus and previously performed compliance and performance reviews of Medicare health plans as a CMS contractor; Sameer Sheth, M.D., a board-certified cardiologist who practiced at Massachusetts General Hospital and served in clinical leadership roles at CareMore, RubiconMD and Oak Street Health; and Jeffrey De Flavio, M.D., co-founder of Pearl Health and founding CEO of Groups Recover Together. Aloth has said cardiology was the top expense affecting his health plan membership with few available solutions, and that he and Sheth combined payer and clinical perspectives to start the company in September 2022.
Business model
Chamber partners with both health plans and cardiology practices to operate value-based care programs for cardiovascular disease. It builds networks of independent cardiologists rather than acquiring practices, supplying a proprietary population health platform, care teams and contracting and operational support. The company frames its economics around converting improved outcomes and avoided utilization into savings that fund providers.
Value-based arrangements with payers and cardiology practices: Chamber supports value-based contracts in which improved coordination and outcomes generate savings, with those savings flowing back to fund provider care.
Traction
As of February 2026 Chamber reported multiple payer partnerships and a network of more than 500 cardiologists across seven states, including several large national Medicare Advantage payers plus Blue Cross Blue Shield and other regional plans. Cumulative funding was reported at $69.5 million. Announced partnerships include Pearl Health (2024) and Humana for Medicare Advantage members (2026).
Latest developments
In February 2026 Chamber closed a $60 million Series A led by Frist Cressey Ventures, with General Catalyst, AlleyCorp, American Family Ventures, Company Ventures, Optum Ventures, Healthworx Ventures and Black Opal Ventures participating and debt from HSBC Innovation Banking; proceeds are earmarked for new markets, expanded payer and practice partnerships, care team growth and further AI investment. In March 2026 the company announced a value-based cardiology partnership with Humana for Medicare Advantage members. Management also points to emerging CMS and CMMI specialist-focused programs, including the LEAD and ACCESS models, as tailwinds.
βΈFull profile β market position, technology, go-to-market, geography, history, risks & controversies
Market position
Chamber operates in value-based specialty care for cardiology, an area described as historically fee-for-service driven and later to receive value-based infrastructure than primary care, nephrology and oncology. Investors include strategic payer-affiliated funds (Optum Ventures, Healthworx), and third-party coverage places it alongside other value-based cardiology companies.
Chamber combines a cardiology-specific, EHR-integrated AI population health platform with operational infrastructure β dedicated care teams, contracting support and physician networks β while leaving practices independent rather than acquiring them. Its founding team pairs payer executive experience with practicing cardiology leadership.
Technology
A cardiology-focused data and intelligence platform, described as a population health platform nuanced for cardiology, that integrates directly with practice electronic health records and embeds workflow-native AI. The AI prioritizes high-risk patients, predicts which patients are on track to deteriorate (for example toward advanced congestive heart failure), identifies gaps in guideline-directed therapy, supports risk stratification and scheduling, and reduces manual chart review.
Go-to-market
Direct partnerships with health plans and with cardiology practices that are brought into Chamber's network, supported by care teams and contracting assistance; the company also markets through its website, blog and industry recognition, and reports a large pipeline of prospective payer partners.
Independent and community cardiology practices and cardiologists, and health plans including large national Medicare Advantage payers, Blue Cross Blue Shield plans and other regional plans; patients with cardiovascular disease are the end beneficiaries.
Geography
United States, with a network of more than 500 cardiologists across seven states as of February 2026 and stated plans for national expansion. Press materials list Washington, D.C. as the release dateline.
History
The company launched in 2022, with Aloth dating the start to September 2022. It publicly introduced its value-based care platform for cardiologists in December 2023, announced $8 million in funding in March 2024, and partnered with Pearl Health on a combined value-based primary care and cardiology model in April 2024. Recognitions followed in 2024 and 2025, including the Washington Business Journal/DC Inno Fire Award and the 2025 New York Digital Health 100 list. In February 2026 Chamber announced a $60 million Series A led by Frist Cressey Ventures, and in March 2026 it announced a partnership with Humana covering value-based cardiology care for Medicare Advantage members.
Risks & controversies
Adoption depends on cardiologists shifting from fee-for-service incentives, which commentary describes as a trust and incentive challenge rather than a technology one; performance also depends on payer willingness to write value-based cardiology contracts and on the quality of underlying data pipelines. The PR Newswire release announcing the Series A was reissued as a correction after an earlier version omitted a quote attribution.
Compiled by commissioned research from 8 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Competitors Β· 2
by search overlapCompanies competing with Chamber Cardio for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline Β· 7
launches, deals, and filingsSeries A led by Frist Cressey Ventures with participation from General Catalyst, AlleyCorp, American Family Ventures, Company Ventures, Optum Ventures, Healthworx Ventures and Black Opal Ventures, plus debt from HSBC Innovation Banking.
$60M source β
Chamber announced $8 million in funding to support cardiologists transitioning to value-based care; a later analysis describes the seed round as $8M led by General Catalyst.
$8M source β
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
βΈResearch sources Β· 8
primary sources listed
- Chamber Cardiochambercardio.com Β· web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Chamber Cardio do?
- Chamber Cardio is a technology-enabled platform helping cardiology practices and health plans deliver value-based cardiovascular care.
- Who are Chamber Cardio's investors?
- Chamber Cardio's investors include AlleyCorp, American Family Ventures, City Light, Frist Cressey Ventures, Optum Ventures.





